Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NUVB
NUVB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NUVB News
Nuvation Bio and Eisai Apply for Lung Cancer Drug Approval
4d ago
seekingalpha
Eisai and Nuvation Bio Submit Marketing Authorization Application for Taletrectinib to Treat Advanced ROS1-Positive Non-Small Cell Lung Cancer, Approved by the European Medicines Agency
4d ago
moomoo
Nuvation Bio Under Investigation, Stock Plummets 25.3%
4d ago
PRnewswire
Nuvation Bio Under Investigation for Securities Fraud
Mar 17 2026
Globenewswire
IBTROZI Shows Unprecedented Durability in ROS1+ Lung Cancer Treatment
Mar 17 2026
PRnewswire
IBTROZI Shows Unprecedented Durability in ROS1+ Lung Cancer Treatment
Mar 17 2026
Newsfilter
Investigation into Nuvation Bio Executives for Breach of Fiduciary Duties
Mar 06 2026
PRnewswire
Investigation into Nuvation Bio Executives for Fiduciary Breach
Mar 06 2026
Newsfilter
Nuvation Bio Under Investigation for Potential Claims
Mar 04 2026
Globenewswire
Knoll Capital Increases Stake in Nuvation Bio by 473,591 Shares
Mar 03 2026
Fool
NUVB Stock 52-Week High and Low Analysis
Mar 03 2026
NASDAQ.COM
Nuvation Bio Reports Strong 2025 Financial Results Driven by Lung Cancer Therapy
Mar 03 2026
NASDAQ.COM
Ouster Inc Reports Strong Q4 Results, Shares Surge
Mar 03 2026
Benzinga
Nuvation Bio Inc. Reports Strong Q4 2025 Earnings and Growth Prospects
Mar 03 2026
seekingalpha
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript
Mar 03 2026
NASDAQ.COM
Nuvation Bio Reports Q4 2025 Earnings Highlights
Mar 03 2026
Yahoo Finance
Show More News
